BRIEF-Denali Therapeutics, Lonza Pharma & Biotech Announce Exclusive Partnership To Develop And Produce Biologic Medicines [Reuters]
Denali Therapeutics Inc. (DNLI)
Last denali therapeutics inc. earnings: 8/6 04:30 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.denalitherapeutics.com
Company Research
Source: Reuters
BRIEF-Denali Therapeutics, Lonza Pharma & Biotech Announce Exclusive Partnership To Develop And Produce Biologic Medicines | Reuters Reuters Staff 1 Min Read Feb 8 (Reuters) - Denali Therapeutics Inc: * DENALI THERAPEUTICS AND LONZA PHARMA & BIOTECH ANNOUNCE EXCLUSIVE PARTNERSHIP TO DEVELOP AND PRODUCE BIOLOGIC MEDICINES * DENALI THERAPEUTICS INC - PARTNERSHIP WITH LONZA PHARMA & BIOTECH AIMS TO DEVELOP DRUGS FOR NEURODEGENERATIVE DISEASES Source text for Eikon: Further company coverage: All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. Š 2018 Reuters. All Rights Reserved. BRIEF-Denali Therapeutics, Lonza Pharma & Biotech Announce Exclusive Partnership To Develop And Produce Biologic Medicines Feb 8 (Reuters) - Denali Therapeutics Inc: * DENALI THERAPEUTICS AND LONZA PHARMA & BIOTECH ANNOUNCE EXCLUSIVE PARTNERSHIP TO DEVELOP AND PRODUCE BIOLOGIC MEDICINES * DENALI THERAPEUTICS INC - PARTNERSHIP WITH LONZA PHARMA & BIOTECH AIMS T
Show less
Read more
Impact Snapshot
Event Time:
DNLI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DNLI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DNLI alerts
High impacting Denali Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
DNLI
News
- Denali Therapeutics Inc. (NASDAQ: DNLI) had its price target lowered by analysts at UBS Group AG from $70.00 to $32.00. They now have a "buy" rating on the stock.MarketBeat
- Flagship Appoints Amy O'Shea as CEO-Partner and Chief Executive Officer of Invaio SciencesPR Newswire
- Gain Therapeutics gets new chief medical officer [Seeking Alpha]Seeking Alpha
- Why Is Denali Therapeutics (DNLI) Up 2.8% Since Last Earnings Report? [Yahoo! Finance]Yahoo! Finance
- Indivi to Collaborate with Biogen to Advance Digital Health Technology and Digital Biomarkers for Parkinson's Disease [Yahoo! Finance]Yahoo! Finance
DNLI
Earnings
- 2/27/24 - Miss
DNLI
Sec Filings
- 4/15/24 - Form 144
- 4/2/24 - Form 4
- 4/1/24 - Form 144
- DNLI's page on the SEC website